Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure

Vaccine

Volumn 26, Issue 20, 2008, Pages 2545-2552

  Kalies, Helen ^a   Grote, Veit ^a   Siedler, Anette ^b   Gröndahl, Britta ^c   Schmitt, Heinz Josef ^c   von Kries, Rüdiger ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Germany; Haemophilus influenzae type b; Hexavalent combination vaccines; Vaccine effectiveness

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ARTICLE; CONFIDENCE INTERVAL; DRUG EFFICACY; GERMANY; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNIZATION; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; COHORT STUDIES; GERMANY; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INFANT; MENINGITIS, HAEMOPHILUS;

EID: 42649133134     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.03.001     Document Type: Article

References (36)

1. von Kries R., Heinrich B., Böhm O., Windfuhr A., and Helwig H. Systemische Haemophilus influenzae erkrankungen in Deutschland: 1992-1995. Monatsschr Kinderh 145 (1997) 136-143
2. Garpenholt O., Silfverdal S.A., Hugosson S., Fredlund H., Bodin L., Romanus V., et al. The impact of Haemophilus influenzae type b vaccination in Sweden. Scand J Infect Dis 28 (1996) 165-169
3. Hargreaves R.M., Slack M.P., Howard A.J., Anderson E., and Ramsay M.E. Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme. BMJ 312 (1996) 160-161
4. Adams W.G., Deaver K.A., Cochi S.L., Plikaytis B.D., Zell E.R., Broome C.V., et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 269 (1993) 221-226
5. Herceg A. The decline of Haemophilus influenzae type b disease in Australia. Commun Dis Intell 21 (1997) 173-176
6. Eskola J., Olander R.-M., Hovi T., Litmanen L., Peltola S., and Käyhty H. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine. Lancet 348 (1996) 1688-1692
7. Pichichero ME, Latiolais T, Bernstein DI, Hosbach P, Christian E, Vidor E, et al. Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-four- and six-month-old infants. Pediatr Infect Dis J 1997; 16:863-70 1994; 50:1064-72.
8. Schmitt H.J. Immunogenicity and reactogenicity of two Haemophilus influenzae type b tetanus conjugate vaccines administered by reconstituting with diphtheria-tetanus-acellular pertussis vaccine or given as separate injections. Proceedings of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, USA (1995) [abstract]
9. Pichichero M.E., Latiolais T., Bernstein D.I., Hosbach P., Christian E., Vidor E., et al. Immunogenicity of combined DTPa-HbOC vaccine (Wyeth-Lederle) in infants and toddler follow-up: evidence of immunologic interference. Annual meeting of the European Society for Pediatric Infectious Diseases congress. Paris, France (1997) Abstract
10. Eskola J., Ward J., Dagan R., Goldblatt D., Zepp F., and Siegrist C.A. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet 354 (1999) 2063-2068
11. Halperin S.A., King J., Law B., Mills E., and Willems P. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses. Clin Infect Dis 28 5 (1999) 995-1001
12. Schmitt H.J., von Kries R., Hassenpflug B., Hermann M., Siedler A., Niessing W., et al. Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines. Pediatr Infect Dis J 20 (2001) 767-774
13. Kalies H., Verstraeten T., Grote V., Meyer N., Siedler A., Schmitt H.-J., et al. 41/2 year follow-up of the effectiveness of DTaP/Hib and DTaP-IPV/Hib combination vaccines in Germany. Pediatr Infect Dis J 23 (2004) 944-950
14. Trotter C.L., Ramsey M.E., and Slack M.P.E. Rising incidences of Haemophilus influenzae type b disease in England and Wales indicates a need for second catch-up vaccination campaign. Comm Dis Pub Health 6 (2003) 55-58
15. Ramsay M.E., McVernon J., Andrews N.J., Heath P.T., and Slack M.P. Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. J Infect Dis 188 (2003) 481-485
16. Prentice R. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 73 (1986) 1-11
17. Barlow W.E., Ichikawa L., Rosner D., and Izumi S. Analysis of case-cohort designs. J Clin Epidemiol 52 (1999) 1165-1172
18. Schmidt E., von Kries R., and Herzig P. Die Erhebungseinheit für pädiatrische Erkrankungen in Deutschland (ESPED). Teil 1: Angebot eines Instruments für epidemiologische Forschung. Monatsschr Kinderh 141 (1993) 758-759
19. Falla T.J., Crook D.W., Brophy L.N., Maskell D., Kroll J.S., and Moxon E.R. PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol 32 (1994) 2382-2386
20. Smith P.J., Battaglia M.P., Huggins V.J., Hoaglin D.C., Roden A.-S., Khare M., et al. Overview of the sampling design and statistical methods used in the national immunization survey. Am J Prev Med 20 4S (2001) 17-24
21. Federal Statistical Office Germany. Statistisches Jahrbuch. Fachserie 1 Reihe 3, Bevölkerung und Erwerbstätigkeit, Haushalte und Familien 2003, Wiesbaden; 2004.
22. Robert Koch Institute. Epidemiol Bull 2 (2000) 9-12 [recommendations of the German Standing Committee on Vaccination (STIKO) at Robert Koch Institute/January 2000, in German]
23. Kalies H., Grote V., Schmitt H.-J., and von Kries R. Immunisation status of children in Germany: temporal trends and regional differences. Eur J Pediatr 165 (2006) 30-36
24. Moulton L.H., Wolff M.C., Brenneman G., and Santosham M. Case-cohort analysis of case-coverage studies of vaccine effectiveness. Am J Epidemiol 142 (1995) 1000-1006
25. Barlow W.E. Robust variance estimation for the case-cohort design. Biometrics 50 4 (1994) 1064-1072
26. Rothman K. Modern Epidemiology (1986), Little, Brown and Company, Boston pp.164-16
27. McVernon J., Andrews N., Slack M., and Ramsay M.E. Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet 361 (2003) 1521-1523
28. Kalies H., Grote V., Verstraeten T., Hessel L., Schmitt H.-J., and von Kries R. The use of combination vaccines has improved timeliness of vaccinations in children. Pediatr Infect Dis J 25 6 (2006) 507-512
29. Laubereau B., Hermann M., Schmitt H.J., Weil J., and von Kries R. Detection of delayed vaccinations: a new approach to visualize vaccine uptake. Epidemiol Infect 128 (2002) 185-192
30. Zepp F., Schmitt H.J., Kaufhold A., et al. Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus conjugate Hib-DTPa-HBV combined vaccine. Eur J Pediatr 156 (1997) 18-24
31. Vidor E., Hoffenbach A., and Fletcher M.A. Haemophilus influenzae type b vaccine: reconstitution of lyophilised PRP-T vaccine with a pertussis containing paediatric combination vaccine, or a change in the primary series immunisation schedule, may modify the serum anti-PRP antibody responses. Curr Med Res Opin 17 (2001) 197-209
32. Centre for Disease Control (CDC). National, state and urban area vaccination coverage among children aged 19-35 months-United States, 2002. MMWR 2003; 52:728-732.
33. Meyer N., Fischer R., Weitkunat R., Crispin A., Schotten K., Bellach B.M., et al. Evalutation of health monitoring in Bavaria by computer-assisted telephone interviews (CATI) in comparison to the German national health examination survey conducted in 1998 by the Robert Koch Institute. Gesundheitswesen 64 6 (2002) 329-336 [in German]
34. Rehmet S., Ammon A., Pfaff G., Bocter N., and Petersen L.R. Cross-sectional study on influenza vaccination, Germany, 1999-2000. Emerg Infect Dis 8 (2002) 1442-1447
35. Poethko-Müller C., Kuhnert R., and Schlaud M. Vaccination coverage and predictors for vaccination level. Results of the German health interview and examination survey for children and adolescents (KiGGS). Bundesgesundheitsblatt 50 851-862 (2007) [in German]
36. Robert Koch Institute. Impfquoten bei den Schuleingangsuntersuchungen, Deutschland 2005, http://www.rki.de/cln_049/nn_199624/DE/Content/Infekt/Impfen/Impfstatus/ImpfstatusDeutschland2005, templateId=raw, property=publicationFile.pdf/ImpfstatusDeutschland2005.pdf; 2007 [accessed August 2007].